Dylan Steen, MD, Cardiology, Cincinnati, OH, University of Cincinnati Medical Center

DylanLauriSteenMD

Cardiology Cincinnati, OH

Adult Congenital Heart Disease, Cardiac Electrophysiology, Nuclear Cardiology

Physician

Dr. Steen is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Steen's full profile

Already have an account?

Education & Training

  • Harvard School of Public HealthM.S., Epidemiology, 2011 - 2014
  • Rutgers Robert Wood Johnson Medical SchoolClass of 2005
  • Cook College, Rutgers UniversityB.S., Biochemistry, 1996 - 2000

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2022
  • MA State Medical License
    MA State Medical License 2012 - 2014
  • VA State Medical License
    VA State Medical License 2011 - 2014
  • FL State Medical License
    FL State Medical License 2009 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Senior Resident of the Year Jackson Memorial Hospital, 2008
  • Intern of the Year Jackson Memorial Hospital, 2006

Publications & Presentations

PubMed

Journal Articles

  • Widening the Path and Window of Opportunity for FDA Approval of Non-Vitamin K Oral Anticoagulant Specific Antidotes and Reversal Agents  
    Patel S, Steen DL, Journal of Thrombosis and Thrombolysis, 1/15/2015
  • Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial  
    O'Donoghue ML, Braunwald E, White HD, Steen DL, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wivio..., JAMA, 1/31/2014
  • Prognostic evaluation of catalytic iron in patients with acute coronary syndromes: observations from OPUS-TIMI 16  
    Steen DL, Cannon CP, Lele SS, Rajapurkar MM, Mukhopadhyay B, Scirica BM, Murphy SA, Morrow DA, Clinical Cardiology, 1/1/2013
  • Join now to see all

Abstracts/Posters

  • Prognostic Utility of Fibroblast Growth Factor-23 after an Acute Coronary Syndrome
    Udell JA, Morrow DA, Braunwald E, Cannon CP, Steen DL, Jarolim P, Lukas MA, Budaj A, Hamm C, Zhou J, Im K, Sabatine MS, O’Donoghue ML, ACC, 1/1/2015
  • Galectin-3 for Heart Failure Risk Stratification in Patients After ACS: Insights from the SOLID-TIMI 52 trial
    Magnani G, O’Donoghue ML, Braunwald E, Steen DL, Jarolim P, Lukas MA, White HD, Lewis B, de Winter RJ, Zhou J, Im K, Cannon CP, Morrow DA, AHA, 1/1/2015
  • Performance Reports and the Utilization of Guideline-Based Therapies in a Large Clinical Trial Population Enrolled after an Acute Coronary Syndrome: Insights from the...
    Steen DL, Cannon CP, Daga S, Lukas MA, Ophuis TO, Gratsiansky N, Crugnale S, Shannon J, O’Donoghue ML, ACC, 1/1/2015
  • Join now to see all

Other

Hospital Affiliations